Catalyst Wire Dossier Catalyst Wire Dossier

Ciclesonide nasal aerosol

ciclesonide · Sumitomo Pharma America, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Ciclesonide nasal aerosol, covering 2014-05-06 to 2014-05-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis [Phase 3]

See pricing